6XSK image
Deposition Date 2020-07-15
Release Date 2021-07-21
Last Version Date 2024-10-16
Entry Detail
PDB ID:
6XSK
Title:
Cryo-EM Structure of Vaccine-Elicited Rhesus Antibody 789-203-3C12 in Complex with Stabilized SI06 (A/Solomon Islands/3/06) Influenza Hemagglutinin Trimer
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.85 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin HA1 chain
Gene (Uniprot):HA
Chain IDs:C (auth: A), E (auth: C), G (auth: E)
Chain Length:343
Number of Molecules:3
Biological Source:Influenza A virus (A/Solomon Islands/3/2006(H1N1))
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin HA2 chain
Gene (Uniprot):HA
Chain IDs:D (auth: B), F (auth: D), H (auth: F)
Chain Length:222
Number of Molecules:3
Biological Source:Influenza A virus (A/Solomon Islands/3/2006(H1N1))
Polymer Type:polypeptide(L)
Molecule:789-203-3C12 Fab Heavy Chain
Chain IDs:B (auth: H), J (auth: G), L (auth: I)
Chain Length:455
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:789-203-3C12 Fab Light Chain
Chain IDs:A (auth: L), I (auth: J), K
Chain Length:214
Number of Molecules:3
Biological Source:Macaca mulatta
Ligand Molecules
Primary Citation
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Immunity 55 2405 2418.e7 (2022)
PMID: 36356572 DOI: 10.1016/j.immuni.2022.10.015

Abstact

Current influenza vaccines predominantly induce immunity to the hypervariable hemagglutinin (HA) head, requiring frequent vaccine reformulation. Conversely, the immunosubdominant yet conserved HA stem harbors a supersite that is targeted by broadly neutralizing antibodies (bnAbs), representing a prime target for universal vaccines. Here, we showed that the co-immunization of two HA stem immunogens derived from group 1 and 2 influenza A viruses elicits cross-group protective immunity and neutralizing antibody responses in mice, ferrets, and nonhuman primates (NHPs). Immunized mice were protected from multiple group 1 and 2 viruses, and all animal models showed broad serum-neutralizing activity. A bnAb isolated from an immunized NHP broadly neutralized and protected against diverse viruses, including H5N1 and H7N9. Genetic and structural analyses revealed strong homology between macaque and human bnAbs, illustrating common biophysical constraints for acquiring cross-group specificity. Vaccine elicitation of stem-directed cross-group-protective immunity represents a step toward the development of broadly protective influenza vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback